CGBIO Secures $38M Deals at IMCAS 2025 Expansion Boost
Paris, France, April 7, 2026 Global Contracts Strengthen Aesthetic Market Leadership In a major development for the global aesthetic...
Alzheimer’s Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology cancer therapy Cell Therapy cGxP Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy GMP GMP compliance Immuno-Oncology immunology Immunotherapy Medical Devices MedTech medtech innovation Monoclonal Antibody Oncology oncology innovation Orphan Drug orphan drug designation patient access Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory approval regulatory compliance targeted therapy
Paris, France, April 7, 2026 Global Contracts Strengthen Aesthetic Market Leadership In a major development for the global aesthetic...
HANGZHOU, China and BERLIN, January 16, 2026 — Zylox-Tonbridge, a Hong Kong–listed medical technology company focused on neurovascular and...
NEW YORK — December 15, 2025 — SK Capital Partners, LP, a private investment firm focused on life sciences...
MALVERN, Pennsylvania, September 10, 2025 — Elutia has announced the sale of its BioEnvelope business to Boston Scientific Corporation...
